Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).
COVID-19
myasthenia gravis
outcome measures
physcial examination
telemedicine
Journal
Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
26
04
2021
received:
30
07
2020
accepted:
04
05
2021
pubmed:
8
5
2021
medline:
1
9
2021
entrez:
7
5
2021
Statut:
ppublish
Résumé
Telemedicine may be particularly well-suited for myasthenia gravis (MG) due to the disorder's need for specialized care, its hallmark fluctuating muscle weakness, and the potential for increased risk of virus exposure among patients with MG during the coronavirus disease 2019 (COVID-19) pandemic during in-person clinical visits. A disease-specific telemedicine physical examination to reflect myasthenic weakness does not currently exist. This paper outlines step-by-step guidance on the fundamentals of a telemedicine assessment for MG. The Myasthenia Gravis Core Exam (MG-CE) is introduced as a MG-specific, telemedicine, physical examination, which contains eight components (ptosis, diplopia, facial strength, bulbar strength, dysarthria, single breath count, arm strength, and sit to stand) and takes approximately 10 minutes to complete. Pre-visit preparation, remote ascertainment of patient-reported outcome scales and visit documentation are also addressed. Additional knowledge gaps in telemedicine specific to MG care are identified for future investigation.
Identifiants
pubmed: 33959997
doi: 10.1002/mus.27260
pmc: PMC9057373
mid: NIHMS1795957
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
270-276Subventions
Organisme : NINDS NIH HHS
ID : U54 NS115054
Pays : United States
Organisme : MGNet
ID : U54 NS115054, which is funded through collaboration between NCATS and NINDS.
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
JAMA Neurol. 2020 Aug 1;77(8):927-928
pubmed: 32329796
Arch Intern Med. 2011 Mar 28;171(6):568-74
pubmed: 21444847
Clin Ther. 2017 May;39(5):1064-1076
pubmed: 28413148
Neurol Clin Pract. 2021 Apr;11(2):e157-e164
pubmed: 33842085
Circulation. 2017 Feb 14;135(7):e24-e44
pubmed: 27998940
J Clin Neuromuscul Dis. 2017 Mar;18(3):135-146
pubmed: 28221304
Ann N Y Acad Sci. 2012 Dec;1274:114-9
pubmed: 23252905
J Neurol Sci. 2020 Jul 15;414:116930
pubmed: 32460041
Muscle Nerve. 2016 Dec;54(6):1015-1022
pubmed: 27220659
Ann N Y Acad Sci. 2003 Sep;998:440-4
pubmed: 14592912
Muscle Nerve. 2020 Aug;62(2):258-261
pubmed: 32447763
Muscle Nerve. 2019 Aug;60(2):147-154
pubmed: 31136007
Muscle Nerve. 2018 Oct;58(4):475-485
pubmed: 29510449
Muscle Nerve. 2020 Jun;61(6):682-691
pubmed: 32297678